{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T02:11:52Z","timestamp":1774491112758,"version":"3.50.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral Biology and Craniofacial Research"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.jobcr.2016.10.005","type":"journal-article","created":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T10:32:01Z","timestamp":1476959521000},"page":"S5-S8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"S1","title":["Management of rhinomaxillary mucormycosis with Posaconazole in immunocompetent patients"],"prefix":"10.1016","volume":"6","author":[{"given":"Sachin","family":"Rai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shikha","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidya","family":"Rattan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jobcr.2016.10.005_bib0095","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/cid\/cir866","article-title":"Epidemiology and clinical manifestations of mucormycosis","volume":"54","author":"Petrikkos","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.jobcr.2016.10.005_bib0100","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/432579","article-title":"Epidemiology and outcome of zygomycosis: a review of 929 reported cases","volume":"41","author":"Roden","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.jobcr.2016.10.005_bib0105","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ijid.2011.02.005","article-title":"Mucormycosis in immunocompetent patients: a case-series of patients with maxillary sinus involvement and a critical review of the literature","volume":"15","author":"Mignogna","year":"2011","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jobcr.2016.10.005_bib0110","first-page":"24","article-title":"Orbital apex syndrome secondary to mucormycosis after a tooth extraction in an immunocompetent patient","volume":"89","author":"Varghese","year":"2010","journal-title":"Ear Nose Throat J"},{"issue":"12","key":"10.1016\/j.jobcr.2016.10.005_bib0115","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1086\/599105","article-title":"Recent advances in the management of mucormycosis: from bench to bedside","volume":"48","author":"Goldstein","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jobcr.2016.10.005_bib0120","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1128\/AAC.46.5.1581-1582.2002","article-title":"In vitro activities of Posaconazole, Itraconazole, Voriconazole, Amphotericin B, and Fluconazole against 37 clinical isolates of zygomycetes","volume":"46","author":"Sun","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jobcr.2016.10.005_bib0125","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1080\/13693780801975576","article-title":"Comparative in vitro activities of Posaconazole, Voriconazole, Itraconazole, and Amphotericin B against Aspergillus and Rhizopus, and synergy testing for Rhizopus","volume":"46","author":"Arikan","year":"2008","journal-title":"Med Mycol"},{"key":"10.1016\/j.jobcr.2016.10.005_bib0130","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1345\/aph.1H157","article-title":"Acute amphotericin B overdose","volume":"40","author":"Burke","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jobcr.2016.10.005_bib0135","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1212\/WNL.42.10.2005","article-title":"Amphotericin B associated leukoencephalopathy","volume":"42","author":"Walker","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.jobcr.2016.10.005_bib0140","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1086\/374553","article-title":"Triad of acute infusion-related reactions associated with liposomal amphotericin B: analysis of clinical and epidemiological characteristics","volume":"36","author":"Roden","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jobcr.2016.10.005_bib0145","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0002-9343(89)80612-6","article-title":"Risk factors for amphotericin B-associated nephrotoxicity","volume":"87","author":"Fisher","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.jobcr.2016.10.005_bib0150","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1053\/jinf.2001.0831","article-title":"Ten years experience in zygomycosis at a tertiary care centre in India","volume":"42","author":"Chakrabarti","year":"2001","journal-title":"J Infect"},{"key":"10.1016\/j.jobcr.2016.10.005_bib0155","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/13693780500464930","article-title":"The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus","volume":"44","author":"Chakrabarti","year":"2006","journal-title":"Med Mycol"},{"key":"10.1016\/j.jobcr.2016.10.005_bib0160","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/pgmj.2008.076463","article-title":"Invasive zygomycosis in India: experience in a tertiary care hospital","volume":"85","author":"Chakrabarti","year":"2009","journal-title":"Postgrad Med J"},{"issue":"S3","key":"10.1016\/j.jobcr.2016.10.005_bib0165","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/1469-0691.12371","article-title":"ESCMID and ECMM Joint Clinical Guidelines for the Diagnosis and Management of Mucormycosis 2013","volume":"20","author":"Cornely","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jobcr.2016.10.005_bib0170","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1128\/AAC.50.2.658-666.2006","article-title":"Pharmacokinetics, safety, and efficacy of Posaconazole in patients with persistent febrile neutropenia or refractory invasive fungal infection","volume":"50","author":"Ullmann","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jobcr.2016.10.005_bib0175","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1086\/500212","article-title":"Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases","volume":"42","author":"van Burik","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jobcr.2016.10.005_bib0180","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1128\/AAC.50.1.126-133.2006","article-title":"Posaconazole as salvage therapy for zygomycosis","volume":"50","author":"Greenberg","year":"2006","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Oral Biology and Craniofacial Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212426816300987?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212426816300987?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:23:44Z","timestamp":1761945824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212426816300987"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":18,"alternative-id":["S2212426816300987"],"URL":"https:\/\/doi.org\/10.1016\/j.jobcr.2016.10.005","relation":{},"ISSN":["2212-4268"],"issn-type":[{"value":"2212-4268","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of rhinomaxillary mucormycosis with Posaconazole in immunocompetent patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral Biology and Craniofacial Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jobcr.2016.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Craniofacial Research Foundation. All rights reserved.","name":"copyright","label":"Copyright"}]}}